Bivalent 5,8,9,13b-tetrahydro-6H-isoquino[1,2-a]isoquinolines and -isoquinolinium salts: novel heterocyclic templates for butyrylcholinesterase inhibitors

Bioorg Med Chem Lett. 2010 May 1;20(9):2946-9. doi: 10.1016/j.bmcl.2010.03.011. Epub 2010 Mar 6.

Abstract

Three different types of homobivalent compounds, 5,8,9,13b-tetrahydro-6H-isoqino[1,2-a]isoquinolines bearing tertiary N-atoms, their quaternary ammonium salts and their dibenzazecine analogues, connected by alkylene spacers of various lengths were synthesized. Compared to the therapeutically used inhibitor galanthamine, some of the bivalent compounds showed much higher inhibitory activities at both cholinesterases in the Ellman test. Surprisingly, not only the quaternary salts, but also the uncharged tertiary compounds exhibited IC(50) values at butyrylcholinesterase in the nanomolar range. Selectivity toward BChE of up to 76-fold was observed.

MeSH terms

  • Butyrylcholinesterase / chemistry*
  • Butyrylcholinesterase / metabolism
  • Cell Line
  • Cholinesterase Inhibitors / chemical synthesis
  • Cholinesterase Inhibitors / chemistry*
  • Cholinesterase Inhibitors / toxicity
  • Heterocyclic Compounds / chemistry*
  • Humans
  • Isoquinolines / chemical synthesis
  • Isoquinolines / chemistry*
  • Isoquinolines / toxicity
  • Quaternary Ammonium Compounds / chemistry*

Substances

  • Cholinesterase Inhibitors
  • Heterocyclic Compounds
  • Isoquinolines
  • Quaternary Ammonium Compounds
  • Butyrylcholinesterase